Details for Patent: 8,371,292
Which drugs does patent 8,371,292 protect, and when does it expire?
Patent 8,371,292 protects ALVESCO, ZETONNA, and OMNARIS, and is included in three NDAs.
This patent has fourteen patent family members in twelve countries.
Summary for Patent: 8,371,292
| Title: | Use of ciclesonide for the treatment of respiratory diseases |
| Abstract: | The invention relates to new method of treatment of respiratory diseases, in particular the treatment of asthmatic children. |
| Inventor(s): | Thomas Bethke, Renate Engelstaetter, Wilhelm Wurst |
| Assignee: | Covis Pharma GmbH , Nycomed Germany Holding GmbH |
| Application Number: | US10/571,311 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Delivery; Dosage form; |
Drugs Protected by US Patent 8,371,292
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | ALVESCO | ciclesonide | AEROSOL, METERED;INHALATION | 021658-002 | Jan 10, 2008 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | MAINTENANCE TREATMENT OF ASTHMA AS PROPHYLACTIC THERAPY IN ADULT AND ADOLESCENT PATIENTS 12 YEARS OF AGE AND OLDER. PATENT CLAIMS METHOD FOR TREATING A RESPIRATORY DISEASE IN A CHILD | ⤷ Start Trial | ||||
| Azurity | ALVESCO | ciclesonide | AEROSOL, METERED;INHALATION | 021658-003 | Jan 10, 2008 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | MAINTENANCE TREATMENT OF ASTHMA AS PROPHYLACTIC THERAPY IN ADULT AND ADOLESCENT PATIENTS 12 YEARS OF AGE AND OLDER. PATENT CLAIMS METHOD FOR TREATING A RESPIRATORY DISEASE IN A CHILD | ⤷ Start Trial | ||||
| Azurity | ZETONNA | ciclesonide | AEROSOL, METERED;NASAL | 202129-001 | Jan 20, 2012 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | TREATMENT OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS IN ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER. PATENT CLAIMS METHODS FOR TREATING A RESPIRATORY DISEASE IN A CHILD | ⤷ Start Trial | ||||
| Azurity | OMNARIS | ciclesonide | SPRAY, METERED;NASAL | 022004-001 | Oct 20, 2006 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | TREATMENT OF NASAL SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER. TREATMENT OF NASAL SYMPTOMS ASSOCIATED W PERENNIAL ALLERGIC RHINITIS IN ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,371,292
| PCT Information | |||
| PCT Filed | September 15, 2004 | PCT Application Number: | PCT/EP2004/052172 |
| PCT Publication Date: | March 24, 2005 | PCT Publication Number: | WO2005/025578 |
International Family Members for US Patent 8,371,292
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2004271744 | ⤷ Start Trial | |||
| Canada | 2538419 | ⤷ Start Trial | |||
| Cyprus | 1117371 | ⤷ Start Trial | |||
| Denmark | 1670482 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
